Labcorp revenue, earnings surge in Q3

By staff writers

October 27, 2020 -- Revenue gains from COVID-19 testing helped propel Labcorp to a 33% increase in revenue in its third quarter.

For the period (end-September 30), LabCorp had revenue of $3.9 billion, up from $2.9 billion in the third quarter of 2019. Organic revenue climbed 31.5% due to COVID-19 testing, according to the company.

Labcorp had third-quarter net income of $703.4 million, compared with $220.7 million a year ago.

Labcorp nabs EUA for new COVID-19 molecular test
The U.S. Food and Drug Administration has awarded Labcorp emergency use authorization (EUA) for a new, high-throughput method that uses heat and technology...
Labcorp debuts combined COVID-19, flu, and RSV test
Labcorp has launched a combined test for COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The single-panel test is now available throughout...
Labcorp to offer total COVID-19 antibody testing for free
Labcorp plans to offer total antibody testing at no charge through patients' doctors in support of increased blood plasma donations for use as a possible...
Labcorp reports revenue dip in Q2
The COVID-19 pandemic resulted in a 3.9% drop in revenue for Labcorp in its second quarter.
Labcorp launches smart laboratory test reports
Labcorp has launched Insight Analytics, intelligent reports that combine national laboratory test values with patient demographics.

Copyright © 2020

Last Updated ls 6/22/2021 4:10:09 PM